| 1 | 20 mg sildenafil citrate by mouth | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 2 | 5% sildenafil cream | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0501件: 50 💬 | 
| 3 | Access program - sildenafil citrate, viagra, revatio | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 4 | Bosentan and sildenafil | Bosentan | 4件: D01227D01227, D02229D02229, D07538D07538, D08514D08514 💬 | EDNRA3件: EDNRA, EDNRB, PDE5A 💬 | Calcium signaling pathway11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 5 | Duo-therapy with sildenafil + bosentan | Bosentan | 4件: D01227D01227, D02229D02229, D07538D07538, D08514D08514 💬 | EDNRA3件: EDNRA, EDNRB, PDE5A 💬 | Calcium signaling pathway11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 6 | Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) | Bosentan | 6件: D01227D01227, D02008D02008, D02229D02229, D07538D07538, D08514D08514, D10135D10135 💬 | EDNRA3件: EDNRA, EDNRB, PDE5A 💬 | Calcium signaling pathway11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 7 | G04be03- sildenafil - sildenafil (citrato) | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 8 | Mono-therapy with sildenafil | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 9 | Oral sildenafil | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 10 | Other: standard of care sildenafil | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0902件: 90, 301 💬 | 
| 11 | Sildenafil | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 00617件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 | 
| 12 | Sildenafil (50 mg) | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0851件: 85 💬 | 
| 13 | Sildenafil (acute-1 hour) | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 2991件: 299 💬 | 
| 14 | Sildenafil (as citrate) | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 15 | Sildenafil (revatio) | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 16 | Sildenafil (revatio) 20 mg tid | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 17 | Sildenafil (subchronic-4 weeks) | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 2991件: 299 💬 | 
| 18 | Sildenafil 20 mg tablets | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 2781件: 278 💬 | 
| 19 | Sildenafil 20mg | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0512件: 51, 86 💬 | 
| 20 | Sildenafil 20mg and bosentan 62.5mg | Bosentan | 4件: D01227D01227, D02229D02229, D07538D07538, D08514D08514 💬 | EDNRA3件: EDNRA, EDNRB, PDE5A 💬 | Calcium signaling pathway11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0512件: 51, 86 💬 | 
| 21 | Sildenafil 40mg oral capsule | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 2991件: 299 💬 | 
| 22 | Sildenafil and losartan | Losartan | 4件: D00357D00357, D02229D02229, D08146D08146, D08514D08514 💬 | AGTR12件: AGTR1, PDE5A 💬 | AGE-RAGE signaling pathway in diabetic complications18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway | 0851件: 85 💬 | 
| 23 | Sildenafil by injection | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 2101件: 210 💬 | 
| 24 | Sildenafil citrate | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0514件: 51, 85, 86, 225 💬 | 
| 25 | Sildenafil citrate (uk-92,480) | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 26 | Sildenafil filmtabletten | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 27 | Sildenafil singly or in association with bosentan | Bosentan | 4件: D01227D01227, D02229D02229, D07538D07538, D08514D08514 💬 | EDNRA3件: EDNRA, EDNRB, PDE5A 💬 | Calcium signaling pathway11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 28 | Sildenafil therapy | Sildenafil | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0511件: 51 💬 | 
| 29 | Sitaxsentan and sildenafil | Sildenafil | 3件: D02229D02229, D07171D07171, D08514D08514 💬 | EDNRA2件: EDNRA, PDE5A 💬 | Calcium signaling pathway9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 30 | Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth | Dextrose, unspecified form | 2件: D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 0861件: 86 💬 | 
| 31 | Tadalafil and sildenafil | Sildenafil | 3件: D02008D02008, D02229D02229, D08514D08514 💬 | PDE5A1件: PDE5A 💬 | Metabolic pathways3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway | 1131件: 113 💬 | 
| 32 | Viagra | - | - | - | - | 0863件: 86, 96, 225 💬 |